300511 雪榕生物
按盤價 
6.300 -0.010 (-0.158%)
6.300 -0.010 (-0.158%) | 2025/06 - 中期 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -9.231 | -49.501 | -11.405 | -16.833 | -15.834 |
| 總資產報酬率 ROA (%) | -2.748 | -14.594 | -4.336 | -6.831 | -6.572 |
| 投入資產回報率 ROIC (%) | -3.413 | -17.661 | -5.035 | -7.788 | -7.536 | 邊際利潤分析 |
| 銷售毛利率 (%) | 1.237 | 3.605 | 8.384 | 10.704 | 5.263 |
| 營業利潤率 (%) | -12.189 | -28.385 | -7.422 | -16.166 | -15.842 |
| 息稅前利潤/營業總收入 (%) | -7.975 | -24.115 | -4.215 | -12.923 | -12.557 |
| 淨利潤/營業總收入 (%) | -12.303 | -28.505 | -7.498 | -16.985 | -16.077 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 117.915 | 33.503 | 71.215 | -1.446 | 45.833 |
| 價值變動淨收益/利潤總額(%) | -1.041 | 0.105 | 1.381 | -2.331 | -0.300 |
| 營業外收支淨額/利潤總額(%) | 0.920 | 0.420 | 0.890 | 1.426 | 2.776 | 償債能力分析 |
| 流動比率 (X) | 0.309 | 0.280 | 0.363 | 0.919 | 0.545 |
| 速動比率 (X) | 0.084 | 0.113 | 0.153 | 0.577 | 0.306 |
| 資產負債率 (%) | 67.475 | 78.640 | 68.876 | 60.073 | 61.878 |
| 帶息債務/全部投入資本 (%) | 51.058 | 66.343 | 56.626 | 47.234 | 51.569 |
| 股東權益/帶息債務 (%) | 87.992 | 44.862 | 71.595 | 101.522 | 86.616 |
| 股東權益/負債合計 (%) | 52.710 | 30.965 | 49.042 | 71.264 | 62.260 |
| 利息保障倍數 (X) | -1.843 | -5.493 | -1.287 | -3.717 | -3.359 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 7.047 | 5.400 | 4.386 | 4.490 | 4.594 |
| 存貨周轉天數 (天) | 76.861 | 66.335 | 67.872 | 71.873 | 70.621 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 29/08/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
